Company intelligence
Alzheimer's Therapeutic Research Institute (ATRI)
Roadmap to prevention The USC Epstein family ATRI accelerates treatments from lab to clinic.
Research Services
San Diego, US
125 employees
Founded 2015
3 public signals
About Alzheimer's Therapeutic Research Institute (ATRI)
We are dedicated to helping the nation and the world confront the problem of Alzheimer’s Disease (AD) by rigorously testing novel treatments and identifying reliable markers for early detection of the disease.
Verified activity
Signals from Alzheimer's Therapeutic Research Institute (ATRI)
3 published signals
Research & Knowledge
Alzheimer's Therapeutic Research Institute (ATRI) published an article highlighting the work of USC Epstein Family ATRI and Michael S. Rafii, MD, PhD in the field of Down syndrome research.
Reported by Alzheimer's Therapeutic Research Institute (ATRI)
Legal & Regulatory
Alzheimer's Therapeutic Research Institute (ATRI) played a role in the progress of the new FDA-approved pTau217 blood test for Alzheimer's disease, the first single-biomarker immunoassay, which allows labs without mass spectrometers to run Alzheimer's disease blood tests.
Reported by Alzheimer's Therapeutic Research Institute (ATRI)
Research & Knowledge
Alzheimer's Therapeutic Research Institute (ATRI) Dr. Charisse Winston received an Alzheimer's Association Research Grant for her project on saliva extracellular vesicles as Alzheimer's diagnostic biomarkers.
Reported by Alzheimer's Therapeutic Research Institute (ATRI)